Sleeve Lobectomy or Pneumonectomy: Optimal Management Strategy Using Decision Analysis Techniques

Annals of Thoracic Surgery

Volumn 76, Issue 6, 2003, Pages 1782-1788

  Ferguson, Mark K ^a   Lehman, Amy G ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HUMAN; LOBECTOMY; LUNG CANCER; LUNG RESECTION; META ANALYSIS; MODEL; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SURVIVAL;

EID: 0344234182     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)01243-8     Document Type: Article

References (44)

1. Price-Thomas C. Conservative resection of the bronchial tree. J R Coll Surg Edinb 1955;1:169-86.
2. Allison PR. Course of thoracic surgery in Groningen. Ann R Coll Surg 1954;25:20-2.
3. Yoshino I, Yokoyama H, Yano T, et al. Comparison of the surgical results of lobectomy with bronchoplasty and pneumonectomy for lung cancer. J Surg Oncol 1997;64:32-5.
4. Suen HC, Meyers BF, Guthrie T, et al. Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies. Ann Thorac Surg 1999;67:1557-62.
5. Lausberg HF, Graeter TP, Wendler O, Demertzis S, Ukena D, Schafers HJ. Bronchial and bronchovascular sleeve resection for treatment of central lung tumors. Ann Thorac Surg 2000;70:367-71.
6. Okada M, Yamagishi H, Satake S, et al. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. J Thorac Cardiovasc Surg 2000;119:814-9.
7. American Joint Committee on Cancer. AJCC staging manual. 6th ed. New York: Springer-Verlag, 2002:167-77.
8. Watanabe Y, Shimizu J, Oda M, et al. Results in 104 patients undergoing bronchoplastic procedures for bronchial lesions. Ann Thorac Surg 1990;50:607-14.
9. Van Schil PE, Brute de la Riviere A, Knaepen PJ, van Swieten HA, Defauw JJ, van den Bosch JM. TNM staging and long-term follow-up after sleeve resection for bronchogenic tumors. Ann Thorac Surg 1991;52:1096-101.
10. Kawahara K, Akamine S, Tsuji H, et al. Bronchoplastic procedures for lung cancer: clinical study in 136 patients. World J Surg 1994;18:822-5.
11. Gaissert HA, Mathisen DJ, Moncure AC, Hilgenberg AD, Grillo HC, Wain JC. Survival and function after sleeve lobectomy for lung cancer. J Thorac Cardiovasc Surg 1996; 111:948-53.
12. Icard P, Regnard JF, Guibert L, Magdeleinat P, Jauffret B, Levasseur P. Survival and prognostic factors in patients undergoing parenchymal saving bronchoplastic operation for primary lung cancer: a series of 110 consecutive cases. Eur J Cardiothorac Surg 1999;15:426-32.
13. Tronc F, Gregoire J, Rouleau J, Deslauriers J. Long-term results of sleeve lobectomy for lung cancer. Eur J Cardiothorac Surg 2000;17:550-6.
14. Fadel E, Yildizeli B, Chapelier AR, Dicenta I, Mussot S, Dartevelle PG. Sleeve lobectomy for bronchogenic cancers: factors affecting survival. Ann Thorac Surg 2002;74:851-8.
15. Ghiribelli C, Voltolini L, Luzzi L, Paladini P, Campione A, Gotti G. Survival after bronchoplastic lobectomy for non small cell lung cancer compared with pneumonectomy according to nodal status. J Cardiovasc Surg (Torino) 2002;43: 103-8.
16. Mezzetti M, Panigalli T, Giuliani L, Raveglia F, Lo Giudice F, Meda S. Personal experience in lung cancer sleeve lobectomy and sleeve pneumonectomy. Ann Thorac Surg 2002;73: 1736-9.
17. Terzi A, Lonardoni A, Falezza G, et al. Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases. Eur J Cardiothorac Surg 2002;21:888-93.
18. Kim YT, Sung SW, Kim JH. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy. Ann Thorac Surg, in press.
19. Mizushima Y, Noto H, Kusajima Y, Yamashita R, Sugiyama S, Kashii T, Kobayashi M. Results of pneumonectomy for non-small cell lung cancer. Acta Oncol 1997;36:493-7.
20. Ferguson MK, Karrison T. Does pneumonectomy for lung cancer adversely influence long-term survival? J Thorac Cardiovasc Surg 2000;119:440-8.
21. Deslauriers J, Gregoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites of recurrences. Ann Thorac Surg, in press.
22. Kotlyarov EV, Rukosuyev AA. Long-term results and patterns of disease recurrence after radical operations for lung cancer. J Thorac Cardiovasc Surg 1991;102:24-8.
23. Ichinose Y, Yano T, Yokoyama H, et al. Postrecurrent survival of patients with non-small-cell lung cancer undergoing a complete resection. J Thorac Cardiovasc Surg 1994;108: 158-61.
24. Yano T, Yokoyama H, Inoue T, et al. The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. J Thorac Cardiovasc Surg 1994;108:680-3.
25. Cangemi V, Volpino P, D'Andrea N, et al. Local and/or distant recurrence in T1-2/N0-1 non-small cell lung cancer. Eur J Cardio-thorac Surg 1995;9:473-8.
26. Harpole DH Jr, Herndon JE, Young WG Jr, Wolfe WG, Sabiston DC Jr. Stage I nonsmall cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76:787-96.
27. Walsh GL, O'Connor M, Willis KM, et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995;60:1563-72.
28. Al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardio-thorac Surg 1997;12:380-4.
29. Thomas PA Jr, Lawrence R, and The Lung Cancer Study Group. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. J Thorac Cardiovasc Surg 1993;106:1053-8.
30. Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung cancer. Ann Thorac Surg 1995,59:863-7.
31. Ginsberg RJ, Rubenstein LV, and Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995;60: 615-23.
32. Dales RE, Belanger R, Shamji FM, Leech J, Crepeau A, Sachs HJ. Quality-of-life following thoracotomy for lung cancer. J Clin Epidemiol 1994;47:1443-9.
33. Zieren HU, Muller JM, Hamberger U, Pichlmaier H. Quality of life after surgical therapy of bronchogenic carcinoma. Eur J Cardio-thorac Surg 1996;10:223-7.
34. Mangione CM, Goldman L, Orav EJ, et al. Health-related quality of life after elective surgery: measurement of longitudinal changes. J Gen Intern Med 1997;12:686-97.
35. Handy JR Jr, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002;122:21-30.
36. Li WWL, Lee TW, Lam SSY, et al. Quality of life following lung cancer resection: video-assisted thoracic surgery vs thoracotomy. Chest 2002;122:584-9.
37. Earle C, Coyle D, Smith A, Agboola O, Evans WK. The cost of radiotherapy at an Ontario regional cancer centre: a re-evaluation. Crit Rev Oncol/Hematol 1997;32:87-93.
38. Coy P, Schaafsma J, Schofield JA. The cost-effectiveness and cost-utility of high-dose palliative radiotherapy for advanced non-small-cell lung cancer. Int J Radiation Oncol Biol Phys 2000;48:1025-33.
39. Earle CC, Evans WK. Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer. Br J Cancer 1999;80:815-20.
40. Sacristan JA, Kennedy-Martin T, Rosell R, et al. Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer. Lung Cancer 2000;28:97-107.
41. Chen Y-M, Peng R-P, Lee Y-C, et al. Paclitaxel plus carboplatin, compared with paclitaxel plus gemicitabine, show similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated. Ann Oncol 2002;13:108-15.
42. Clegg A, Scott DA, Hewitson P, Sidhu M, Waugh N. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Thorax 2002;57:20-8.
43. Lees M, Aristides M, Maniadakis N, McKendrick J, Botwood N, Stephenson D. Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of non-small cell lung cancer. Pharmacoeconomics 2002;20:325-37.
44. Elixhauser A, Halpern M, Schmier T, Luce BR. Health care CBA and CEA from 1991 to 1996: an updated bibliography. Med Care 1998;36(Suppl 5):MS1-147.